Corcept Therapeutics Incorporated (CORT)

Days of sales outstanding (DSO)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Receivables turnover		11.26	12.23	12.61	12.87	15.38
DSO	days	32.40	29.84	28.95	28.36	23.73

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 11.26
= 32.40

The Days Sales Outstanding (DSO) ratio measures the average number of days it takes for a company to collect payment after a sale has been made. In the case of Corcept Therapeutics Inc, we observe the following trend in DSO over the last five years:

- As of December 31, 2023, the DSO was 31.12 days, showing an increase from the previous year's 28.21 days.
- In 2022, the DSO was 28.21 days, which was slightly higher than 2021's DSO of 27.55 days.
- The DSO in 2021 was 27.55 days, up from 27.02 days in 2020.
- 2019 had the lowest DSO at 23.73 days.

The increasing trend in DSO indicates that Corcept Therapeutics Inc may be experiencing challenges in collecting payments from its customers in a timely manner. This could potentially impact the company's cash flow and liquidity position. It would be prudent for the company to review its credit policies, collections procedures, and customer relationships to improve its DSO and strengthen its overall financial health.